Viking announces Russian launch of its new 3DHD Vision System

Viking Systems, Inc., a leading worldwide developer, manufacturer and marketer of 3D and 2D visualization solutions for complex minimally invasive surgery, announces the Russian launch of its new Viking 3DHD Vision System at The XIV Russian Society of Endoscopic Surgeons Conference, in Moscow. The Conference takes place on February 16 – 18, 2011.

Viking's 3D Vision System will be demonstrated in a broadcast of a minimally invasive laparoscopic surgery at this conference, being held at the prestigious Vishnevsky Institute of Surgery of the Russian Academy of Medical Sciences. More than 500 leading experts in endoscopic surgery from Russia, Commonwealth of Independent States ("CIS") countries and Europe are expected to be in attendance at the Conference.

Jed Kennedy, President and CEO of Viking Systems is scheduled to introduce the 3D broadcast. Kennedy commented, "We believe this conference will provide Viking with a powerful platform to launch our new 3DHD Vision System into the Russian marketplace, and to gain the attention of surgeons throughout the CIS and other European countries. The conference broadcast of the surgery using our 3D vision system is expected to demonstrate the many advantages that it has, its enhanced capabilities compared with 2D systems, and how it can improve the quality of patient care, while reducing procedure time and costs."

Source:

 Viking Systems, Inc

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Genetic variant identified as potential predictor for severe ulcerative colitis